U
AGN

UBS’s Allergan Inc AGN Stock Holding History

UBS’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$98.1M Buy
550,627
+25,669
+5% +$4.26M 0.07% 270
2014
Q2 		$88.8M Sell
524,958
-97,822
-16% -$15.2M 0.07% 281
2014
Q1 		$77.3M Sell
622,780
-204,892
-25% -$24.9M 0.07% 279
2013
Q4 		$91.9M Buy
827,672
+33,000
+4% +$3.15M 0.09% 242
2013
Q3 		$71.9M Buy
794,672
+354,199
+80% +$31.8M 0.07% 260
2013
Q2 		$37.1M Buy
+440,473
New +$45.7M 0.04% 410

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS's AGN Position: Q3 2014 in Review

UBS increased its Allergan Inc (AGN) stake by 4.9% in Q3 2014, buying an estimated $4.26M and bringing the position to 550,627 shares worth $98.1M. The position accounts for 0.07% of the portfolio, ranked #270.

UBS first reported a position in AGN in Q2 2013 and has held it in 6 quarters since. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • UBS held 550,627 shares of Allergan Inc worth $98.1M as of Q3 2014.
  • UBS bought 25,669 Allergan Inc shares in Q3 2014, an estimated $4.26M.
  • Allergan Inc made up 0.07% of UBS's portfolio in Q3 2014, its #270 holding.
  • UBS first reported a position in Allergan Inc in Q2 2013 and has held it in 6 quarters since.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.